Black Hawk Acquisition Corporation cash flow statement BKHAU

In fiscal 2025, which ended Nov 30, 2025, Black Hawk Acquisition Corporation used $650,321 of cash from operations, down 17.5% from the year before.

USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the year before.

Line
FY 2026
Aug 31, 2026
FY 2025
Nov 30, 2025
FY 2024
Nov 30, 2024
Operating
Operating cash flow
-1
+8.0%
-1
-17.5%
-1
Investing
Investing cash flow
-2
-103.6%
50
+172.5%
-69
Financing
Financing cash flow
2
+104.7%
-50
-171.2%
70
Ratios
Cash conversion
-0.43x
-0.49x
-0.29x
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. The first column is the trailing twelve months through the latest quarter. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
BKHA (Nasdaq), BKHAR (Nasdaq), BKHAU (Nasdaq)
Fiscal year ends
November 30
Headquarters
Danville, CA
SEC filer status
, Emerging growth company
SEC CIK
2000775

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.